| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4565112
Max Phase: Preclinical
Molecular Formula: C19H12Cl2FN3OS
Molecular Weight: 420.30
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Fc1ccc(-c2nc3sccn3c2/C=N/OCc2ccc(Cl)c(Cl)c2)cc1
Standard InChI: InChI=1S/C19H12Cl2FN3OS/c20-15-6-1-12(9-16(15)21)11-26-23-10-17-18(13-2-4-14(22)5-3-13)24-19-25(17)7-8-27-19/h1-10H,11H2/b23-10+
Standard InChI Key: QLNJBWXLHOCOFI-AUEPDCJTSA-N
Associated Targets(Human)
Nuclear receptor subfamily 1 group I member 3 655 Activities
HepG2 196354 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 420.30 | Molecular Weight (Monoisotopic): 419.0062 | AlogP: 6.06 | #Rotatable Bonds: 5 |
| Polar Surface Area: 38.89 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: 2.60 | CX LogP: 5.92 | CX LogD: 5.92 |
| Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.29 | Np Likeness Score: -2.09 |
References
| 1. Liang D, Li L, Lynch C, Diethelm-Varela B, Xia M, Xue F, Wang H.. (2019) DL5050, a Selective Agonist for the Human Constitutive Androstane Receptor., 10 (7): [PMID:31312405] [10.1021/acsmedchemlett.9b00079] |
Source
Source(1):